178 related articles for article (PubMed ID: 36354102)
1. Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis.
Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q;
Jpn J Clin Oncol; 2023 Jan; 53(1):26-34. PubMed ID: 36354102
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and safety of lateral pelvic lymph node dissection for elderly patients with middle-low rectal cancer: results of a large multicenter lateral node collaborative group study in China.
Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q
Tech Coloproctol; 2023 Aug; 27(8):655-664. PubMed ID: 36515808
[TBL] [Abstract][Full Text] [Related]
3. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
4. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
[No Abstract] [Full Text] [Related]
5. [Short-term efficacy of robotic-assisted total mesorectal excision with and without lateral lymph node dissection for mid-low advanced rectal cancer: a propensity score matching analysis].
Shi FY; Zhang L; Qin Q; Jin X; Hu CH; Yu TY; Ma L; Wang GH; Wu H; Xia P; Sun XJ; She JJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):370-376. PubMed ID: 32306605
[No Abstract] [Full Text] [Related]
6. Lateral lymph node dissection for mid-to-low rectal cancer: is it safe and effective in a practice-based cohort?
Numata M; Tamagawa H; Kazama K; Kawahara S; Sawazaki S; Aoyama T; Maezawa Y; Kano K; Higuchi A; Godai T; Saigusa Y; Saeki H; Yukawa N; Rino Y
BMC Surg; 2021 Jan; 21(1):51. PubMed ID: 33478441
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer: A Subgroup Analysis of a Large Multicenter Cohort Study in Japan.
Yamaguchi T; Konishi T; Kinugasa Y; Yamamoto S; Akiyoshi T; Okamura R; Ito M; Nishimura Y; Shiozawa M; Yamaguchi S; Hida K; Sakai Y; Watanabe M
Dis Colon Rectum; 2017 Sep; 60(9):954-964. PubMed ID: 28796734
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery.
Hajibandeh S; Hajibandeh S; Matthews J; Palmer L; Maw A
Surgery; 2020 Sep; 168(3):486-496. PubMed ID: 32620303
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
[TBL] [Abstract][Full Text] [Related]
10. Short- and long-term outcomes of laparoscopic versus open selective lateral pelvic lymph node dissection for locally advanced middle-low rectal cancer: Results of a multicentre lateral node study in China.
Tang J; Zhou S; Zhao W; Lou Z; Liang J; Feng B; Yang Y; Wang X; Liu Q;
Colorectal Dis; 2022 Nov; 24(11):1325-1334. PubMed ID: 35713974
[TBL] [Abstract][Full Text] [Related]
11. Outcome of lateral pelvic lymph node dissection with total mesorectal excision in treatment of rectal cancer: A systematic review and meta-analysis.
Emile SH; Elfeki H; Shalaby M; Sakr A; Kim NK
Surgery; 2021 May; 169(5):1005-1015. PubMed ID: 33317903
[TBL] [Abstract][Full Text] [Related]
12. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212).
Ito M; Kobayashi A; Fujita S; Mizusawa J; Kanemitsu Y; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
Eur J Surg Oncol; 2018 Apr; 44(4):463-468. PubMed ID: 29428473
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the short-term surgical outcomes of lateral lymph node dissection for low rectal cancer using a robotic-assisted transabdominal approach alone or supported by a transanal approach.
Tokunaga T; Kashihara H; Yoshikawa K; Nakao T; Nishi M; Takasu C; Wada Y; Yoshimoto T; Shimada M
Surg Endosc; 2024 Apr; 38(4):2070-2077. PubMed ID: 38438675
[TBL] [Abstract][Full Text] [Related]
14. [Feasibility of a three-sided encapsulation procedure based on fascia anatomy in laparoscopic lateral lymph node dissection for middle and low rectal cancer].
Li WJ; Diao DC; Lin JX; Wang JH; Liao WL; Tang X; Xie JX; Ao L; Zhang XY; Yi XJ; Feng XC; Li HM; Lu XQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):968-976. PubMed ID: 37849268
[No Abstract] [Full Text] [Related]
15. [Comparison on efficacy between fascia-oriented versus vascular-oriented lateral lymph node dissection in patients with rectal cancer].
Wang ZJ; Liu Z; Liang JW; Zhang MG; Mei SW; Shen HY; Chen JN; Li J; Zhao FQ; Wei FZ; Xiao TX; Liu Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jul; 24(7):611-618. PubMed ID: 34289546
[No Abstract] [Full Text] [Related]
16. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
[TBL] [Abstract][Full Text] [Related]
17. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
[No Abstract] [Full Text] [Related]
18. Short- and long-term outcomes of laparoscopic versus open lateral lymph node dissection for locally advanced middle/lower rectal cancer using a propensity score-matched analysis.
Watanabe J; Ishibe A; Suwa Y; Ozawa M; Nakagawa K; Suwa H; Ota M; Kunisaki C; Endo I
Surg Endosc; 2021 Aug; 35(8):4427-4435. PubMed ID: 32875413
[TBL] [Abstract][Full Text] [Related]
19. Oncological outcomes of robotic-assisted laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer.
Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Furutani A; Manabe S; Yamaoka Y; Hino H
Surg Endosc; 2018 Nov; 32(11):4498-4505. PubMed ID: 29721748
[TBL] [Abstract][Full Text] [Related]
20. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
